‘This gives hope’: A third COVID-19 vaccine dose can boost protection for organ transplant recipients
Despite poor protection after two shots, an extra dose helps some according to researchers at Johns Hopkins University.
Despite poor protection after two shots, an extra dose helps some according to researchers at Johns Hopkins University.
In January, the director-general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, issued a blunt warning. The world was ″on the brink of a catastrophic moral failure,″ he said. Wealthy countries were buying up available COVID-19 vaccines, leaving tiny amounts for others—a replay of what happened during the 2009 influenza pandemic. ″The price of … Continued
Last week, an international collaboration that went looking for known or novel viruses in pneumonia patients in Malaysia reported that in eight children, they found signs of a coronavirus that may have originated in dogs. Earlier this year another group reported a coronavirus that appears to have jumped from pigs to several children in Haiti. … Continued
In the April 30 issue of Science Magazine, researchers use careful structural analyses to reveal how an early spike protein mutation accelerated the pandemic and how it will shape the next vaccines.
As described in a AAAS report released today, “the COVID-19 pandemic provided … a unique opportunity to prove that AI could be harnessed for the benefit of all humanity, and AI developers seized the moment.”
Early studies suggest COVID-19 vaccine protection varies by ailment and treatment For Eva Schrezenmeier, a nephrologist at Charité University Hospital in Berlin, the news was sobering: Among 40 patients with transplanted kidneys at her hospital who’d been vaccinated against COVID-19, only one was churning out the antibodies that would likely protect him from the disease. … Continued
In 2017, three leading vaccine researchers submitted a grant application with an ambitious goal. At the time, no one had proved a vaccine could stop even a single beta coronavirus—the notorious viral group then known to include the lethal agents of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), as well as … Continued
James Crowe Jr., MD, a physician-scientist at Vanderbilt University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award. The ninth annual Golden Goose Award ceremony on Dec. 1 will recognize Crowe and two other federally funded research teams for their scientific … Continued
The American Association for the Advancement of Science and the Science family of journals are applying formidable resources to keep the scientific community and the public well informed on the coronavirus pandemic. Science, published by AAAS, has shared research findings and made data swiftly available over recent weeks to spur scientific advances, outline public health … Continued
As the research community and decision-makers worldwide respond to the coronavirus pandemic, Science and AAAS are working tirelessly to provide credible, evidence-based information and bring you the latest research and commentary, along with extensive news coverage of the crisis. This critical work has been generously supported by the Pulitzer Center, Google News, and a growing … Continued